Spectral Medical Inc. (TSE:EDT – Get Free Report) shares crossed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of C$1.39 and traded as high as C$1.42. Spectral Medical shares last traded at C$1.38, with a volume of 21,921 shares trading hands.
Spectral Medical Price Performance
The company has a debt-to-equity ratio of 26.03, a quick ratio of 0.45 and a current ratio of 0.61. The company has a market cap of C$404.92 million, a P/E ratio of -10.62 and a beta of 0.82. The firm’s fifty day moving average is C$1.39 and its two-hundred day moving average is C$1.35.
Spectral Medical (TSE:EDT – Get Free Report) last announced its quarterly earnings data on Friday, May 8th. The company reported C($0.01) EPS for the quarter. The firm had revenue of C$0.89 million during the quarter. As a group, analysts anticipate that Spectral Medical Inc. will post -0.05 earnings per share for the current fiscal year.
Spectral Medical Company Profile
Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation. The segments of the group are Spectral Medical Inc, which is the key revenue-generating segment that manufactures and sells its EAA diagnostic and certain proprietary reagents; Dialco Medical Inc segment; and Corporate.
See Also
- Five stocks we like better than Spectral Medical
- The Bank of Mom and Dad Is Booming—3 Stocks to Watch
- Corning Is Paving AI’s Future With Glass
- Why’s Amazon Suddenly Lagging the S&P 500, and Is It a Warning?
- Crypto Winter Is Here: 3 Stocks To Put On Ice This Summer
Receive News & Ratings for Spectral Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Medical and related companies with MarketBeat.com's FREE daily email newsletter.
